mapping the effectiveness and risks of glp-1 receptor agonists pdf Glucagon-Like Peptide-1 (GLP-1) Agonists: Exploring Their Impact on Diabetes, Obesity, Cardiovascular Health Through a Comprehensive Literature Review Free Comparison Chart: GLP-1 and
Description
doi: 10.1016/j.arth.2023.12.023
To identify the eligible RCTs, two researchers independently conducted article selection in two stages: initial title/abstract screening, then full-text review
00014-3/asset/c6c68f71-1303-4dbd-81fc-c7e57d64925d/main.assets/gr2_lrg.jpg)
Patients with T1D are equally affected by the obesity epidemic, and they have experienced a rapid increase in the prevalence of obesity in the last few years (36)
Ma B, Wang X, Ren H, Li Y, Zhang H, Yang M, et al
and agree to be accountable for all aspects of the work
Weghuber D, Forslund A, Ahlstrm H, Alderborn A, Bergstrm K, Brunner S, et al
